These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3716339)

  • 21. [The effectiveness of Cavinton in retinal and choroid circulatory disturbances: I. Review of literature and material elaboration (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Zielińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):147-8. PubMed ID: 7392516
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 23. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacodynamic action of cavinton on regional volume blood flow, central hemodynamics and the bioelectric activity of the brain in the acute stage of a cerebral infarct].
    Miagi MA; Tomberg TA; Kauba TF; Rekand TE; Taba PM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(1):46-50. PubMed ID: 3825388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J; Camart JF
    LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral regulation-cerebral regulators.
    Braun P
    Ther Hung; 1980; 28(3):98-104. PubMed ID: 7221974
    [No Abstract]   [Full Text] [Related]  

  • 27. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cavinton prevention of neurosensory hypoacousis in patients with different forms of tuberculosis].
    Maliavina US; Ovchinnikov IuM; Fasenko VP; Maliev BM; Kalinina MV; Dadasheva BB
    Vestn Otorinolaringol; 2003; (3):35-40. PubMed ID: 12847806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of Cavinton effect in elderly diabetic patients.
    Boda J; Karsay K; Czakó L; Fügi S; Kovács A; Koncz I; Maczkó PA
    Ther Hung; 1989; 37(3):176-80. PubMed ID: 2588202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of vinpotropile in chronic brain ishemia].
    Ivanova NE; Panuntsev VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):73-5. PubMed ID: 18689011
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cavinton in the treatment of ischemic cerebral stroke. Clinical and computerized-tomographic evaluation].
    Domzał T; Kozłowski P; Zaleska B
    Neurol Neurochir Pol; 1986; 20(3):234-40. PubMed ID: 3537828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 33. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of vascular retinal lesions with Cavinton (author's transl)].
    Oláh Z; Potocký M
    Cesk Oftalmol; 1981 Jan; 37(1):19-23. PubMed ID: 7471250
    [No Abstract]   [Full Text] [Related]  

  • 35. [The evaluation of the efficacy of antihypoxic agents lowering hemoglobin oxygen affinity in acute cerebral ischemia].
    Plotnikova TM; Plotnikov MB; Bazhenova TG
    Biull Eksp Biol Med; 1991 Feb; 111(2):170-2. PubMed ID: 1854961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effectiveness of cavinton in retinal and choroid circulatory disturbances: II. Results of own investigations and discussion (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Ziellińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):149-52. PubMed ID: 7392517
    [No Abstract]   [Full Text] [Related]  

  • 37. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in lipoproteins in response to Cavinton administration in aged hyperlipaemic patients.
    Banga I; Gergely I
    Ther Hung; 1982; 30(1):25-9. PubMed ID: 6926906
    [No Abstract]   [Full Text] [Related]  

  • 39. Action of Cavinton on hearing defects of different origin.
    Jasper A
    Ther Hung; 1978; 26(4):181-4. PubMed ID: 751275
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic action of Cavinton in hearing defects of neurological origin.
    Ordögh B; Sárossy D; Klimstein G
    Ther Hung; 1978; 26(1):16-9. PubMed ID: 663871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.